In(OTf)3-catalyzed synthesis of 2-styryl quinolines: scope and limitations of metal Lewis acids for tandem Friedländer annulation–Knoevenagel condensation

Dinesh Kumar, Asim Kumar, Mohammad Mohsin Qadri, Md. Imam Ansari, Abhishek Gautam and Asit K. Chakraborti*
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S. A. S. Nagar, 160 062, Punjab, India. E-mail: akchakraborti@niper.ac.in; akchakraborti@rediffmail.com

Received 17th September 2014 , Accepted 1st December 2014

First published on 1st December 2014


Abstract

The catalytic potential of different metal Lewis acids has been assessed for the one-pot tandem Friedländer annulation and Knoevenagel condensation involving 2-aminobenzophenone, ethyl acetoacetate, and benzaldehyde to form 2-styryl quinoline under solvent free conditions. While various metal Lewis acids were effective in promoting the Friedländer annulation step, In(OTf)3 was the only effective catalyst for the subsequent Knoevenagel condensation reaction suggesting In(OTf)3 as the stand-alone catalyst for the tandem Friedländer–Knoevenagel reaction to form 2-styryl quinolines. The protocol is compatible with different variations of aromatic/hetero-aromatic aldehydes and α,β unsaturated aromatic aldehydes giving highly functionalized 2-aryl/heteroaryl vinyl quinolines. The catalyst can be recovered and reused to afford the desired product in very good to excellent yields.


Introduction

Quinolines are an important class of N-heterocyclic compounds because of the wide occurrence of the quinoline moiety in natural products1 and biologically active compounds.2 Amongst the various quinoline derivatives, 2-styryl quinolines (SQLs) continue to draw interest from synthetic organic/medicinal chemists as they have emerged as a new class of HIV-integrase inhibitors devoid of cytotoxicity.3 The reported synthesis of SQLs (Scheme 1) are the (i) classical Knoevenagel condensation of 2-methylquinolines with an aldehyde in acetic anhydride under reflux (140 °C) for a prolonged period (∼16 h) (Route A)3 (ii) two stage process of ceric ammonium nitrate (CAN)-catalyzed vinylogous type-II Povarov reaction involving arylamines, cinnamaldehydes, and vinyl ethers to form the intermediate tetrahydroquinolines followed by DDQ-promoted dehydrogenative aromatization (Route B),4 and (iii) microwave-assisted coupling-isomerization reaction (MACIR) involving 2-bromo/iodo aniline and substituted propargyl alcohols in the presence of transition metal catalysts and DBU (2 equiv.) (Route C).5
image file: c4ra10613j-s1.tif
Scheme 1 Various strategies for the synthesis of 2-styryl quinoline.

These reported procedures have several drawbacks: (i) the lack of commercial availability of the starting materials such as the 2-methylquinolines (Route A) and the 2-styryl propargyl alcohols (Route C) which would require additional synthetic efforts; (ii) the use of costly transition metal catalysts and large excess of organic base (DBU) (Route C); (iii) requirement of stoichiometric quantities of toxic DDQ as dehydrogenating agent to convert the intermediately formed tetrahydroquinoline to quinoline (Route B); (iv) necessity of special apparatus (e.g., microwave reactor) (Route C); (v) high reaction temperature, prolonged reaction period, and the use of volatile organic solvents (THF, DCM) etc. The reaction sequence under Route B may also proceed via the alternative diene framework (the exocyclic α,β-unsaturated imine system) involving inverse electron demand Diels–Alder (DAINV) reaction leading to form 1,4-dihydropyridines (I) as the side products (Scheme 2).6 Further, the Route B may also lead to the formation of 2-methyl-1,2,3,4-tetrahydroquinolines (II) as side product via the cycloaddition reaction between the vinyl ether and the in situ formed imine (due to the CAN-catalysed reaction between the aryl amine and another molecule of the vinyl ether) that decreases the overall yield of the desired SQLs (Scheme 2).7


image file: c4ra10613j-s2.tif
Scheme 2 Formation of side products during the CAN-catalysed vinylogous type-II Povarov reaction following Route B under Scheme 1.

A direct synthesis following Route D involving the one-pot tandem Friedländer annulation–Knoevenagel condensation sequence would provide a convenient synthesis of the 2-SQLs and offer means for diversification to generate functional materials and broaden the scope for pharmacophoric modification (Fig. 1).


image file: c4ra10613j-f1.tif
Fig. 1 Scope for structural diversification of 2-styryl quinolines obtained by Route D under Scheme 1.

In order to overcome the drawbacks of the reported procedures the Route D appears to be suitable but there is only one report.8 Thus, a convenient, rapid and high yielding synthetic method is needed to fulfill the timely supply of the designed molecules for biological evaluation9 and enrichment of medicinal chemists' tool box.10 Herein we describe an extremely efficient catalytic procedure for the domino synthesis of 2-SQLs with structural diversity.

Results and discussion

In search for a more convenient and improved method of synthesis for the titled compounds following the one-pot tandem reaction strategy (Route D, Scheme 1) it was considered that suitable catalytic assistance during the Friedländer annulation and Knoevenagel condensation steps would offer high yields in shorter period under milder reaction conditions.

The adverse effect of the manufacturing processes of drugs and pharmaceuticals on the environment urges for sustainable development.11 The major drive towards this initiative is the replacement of volatile organic solvents (VOSs) by solvent free condition12 as VOSs are major contributors to environmental pollution due to their abundant use (more than 85% of the total mass utilization of a chemical process) and incomplete recovery efficiency (50–80%).13

It was hypothesized that a catalyst which acts via the electrophilic activation strategy would promote both the steps, the Friedländer annulation (step 1) and the Knoevenagel condensation reaction (step 2). In a model study the tandem Friedländer annulation–Knoevenagel condensation reaction involving 2-aminobenzophenone 1, ethyl acetoacetate 2, and benzaldehyde 3 used in equimolar amounts was performed at 100 °C under solvent free condition in the presence of various metal halides, tetrafluoroborates, perchlorates, and triflates (Table 1). Since the reaction is expected to proceed via the intermediate formation of the 2-methylquinoline derivative 4a to afford the final 2-SQL 5, in each case the progress of the reaction was monitored by GC-MS to assess the conversion to 4a after 1 h of the treatment of 1 with 2 followed by addition of 3 and isolating 5 after another 5 h.

Table 1 Assessment of the catalytic potential of different metal Lewis acids and [Hmim]TFA for one-pot tandem Friedländer annulation–Knoevenagel condensation involving 1, 2, and 3 to form the 2-styryl quinoline 5 via the 2-methylquinoline 4aa

image file: c4ra10613j-u1.tif

Entry Catalyst 4a/Yieldb (%) 5/Yieldc (%)
a 1 (0.197 g, 1 mmol) was treated with 2 (0.13 g, 1 mmol, 1 equiv.) in the presence of different metal Lewis acid (10 mol%) under neat condition at 100 °C (oil bath) for 1 h followed by addition of 3 (0.106 g, 1 mmol, 1 equiv.) and continuation of the reaction for further 5 h.b Conversion to 4a (GC-MS).c Isolated yield of 5.d The yields of 5 were 41 and 72% in performing the reaction for 2 and 10 h, respectively.e The reaction was carried out using 10 mol% of [Hmim]TFA.f The reaction was carried out using 50 mol% of [Hmim]TFA.g The reaction was carried out using 50 mol% of TFA.
1 Fe(BF4)2·xH2O 70 25
2 Zn(BF4)2 100 30
3 AgBF4 83 35
4 Cu(BF4)2 85 36
5 Co(BF4)2 75 31
6 LiClO4 40 Traces
7 Fe(ClO4)3·xH2O 75 25
8 Zn(ClO4)2·xH2O 100 35
9 ZrO(ClO4)3·xH2O 82 Traces
10 Bi(ClO4)3·xH2O 80 25
11 Mg(ClO4)2·6H2O 96 60
12 Cu(ClO4)2·6H2O 88 42
13 In(ClO4)3·6H2O 85 61
14 Zn(OTf)2 100 45
15 Mg(OTf)2 94 68
16 Yb(OTf)3·xH2O 86 35
17 Eu(OTf)3 89 36
18 Er(OTf)3 96 25
19 AgOTf 73 20
20 In(OTf)3 100 82
21 Cu(OTf)2 92 30
22 Sc(OTf)3 94 65
23 Gd(OTf)3 99 35
24 La(OTf)3 88 20
25 Sm(OTf)3 94 45
26 Er(OTf)3 96 52
27 Dy(OTf)3 99 36
28 Nd(OTf)3 92 41
29 Ho(OTf)3 87 52
30 Al(OTf)3 98 50
31 ZrCl4 84 20
32 GaCl3 84 35
33 NbCl5 72 32
34 HfCl4 99 44
35 InF3 92 62
36 InCl3 96 68d
37 InBr3 84 58
38 InI3 85 55
39 In(NO3)3·xH2O 78 55
40 In(OAc)3 72 48
41 In (powder) 52 Traces
42 In (pieces) 35 Traces
43 None 3 Traces
44 [Hmim]TFA Nil Nile
45 [Hmim]TFA 90 80f
46 CF3CO2H Nil Nilg


Most of the metal salts exhibited good catalytic potential to promote the Friedländer annulation (70–100% GC-MS conversion to 4a). However, In(OTf)3 emerged as the stand-alone catalyst for the tandem Friedländer annulation–Knoevenagel condensation to afford 5 in excellent yield (82%). The next best results (63–70% yields) were obtained with InCl3, Mg(OTf)2, Sc(OTf)3, In(ClO4)3, and Mg(ClO4)2·6H2O, respectively. The results further reveal that the Knoevenagel condensation step is the most critical stage of the tandem process for the one-pot synthesis of 2-styryl quinolines.

We observed that the only report on the synthesis of 2-styryl quinolines following this strategy involves the use of 50 mol% of the ionic liquid (IL) [Hmim]TFA.8 Thus, a comparison of the catalytic efficiency of [Hmim]TFA with that of In(OTf)3 is relevant. The use of 10 mol% of [Hmim]TFA did not produce any significant amount of 5 (Table 1, entry 44) suggesting its inefficiency for catalytic purpose that establishes the superiority of In(OTf)3. To assess whether the ability of [Hmim]TFA, used in 50 mol%, to form 5 could be due to the associated trifluoroacetic acid (used in molar equivalent with imidazole to form [Hmim]TFA) the reaction was performed in the presence of 50 mol% of trifluoroacetic acid. However, no significant amount of 5 was obtained (Table 1, entry 46). This indicated that the comparable yield (Table 1, entry 45) obtained in using [Hmim]TFA (50 mol%) may not be a general Brönsted acid-catalysed event and could be due to the hydrogen bond (HB) formation ability of the Hmim cation through its C-2 proton.14 We have demonstrated that the HB formation ability of the C-2 proton of the MeIm cation plays significant role in attributing the organo-catalytic potential of N-methylimidazole-based ILs in promoting various organic reactions.15 The influence of HB also plays critical/significant role in various organic reactions under metal-free16 or metal-assisted17 environment. However, in the present case the requirement of 50 mol% of [Hmim]TFA as the hydrogen-bond mediated electrophilic activation agent reveals the requirement of a more stronger electrophilic activation catalyst. This brings the rationale of selecting metal-derived Lewis acid catalysts and In(OTf)3 is found to be the most effective catalyst.

The Friedländer annulation to form 2-methylquinolines has been reported in the presence of Zn(OTf)2 under microwave irradiation.18 Although the conversion to 4a (Table 1, entry 14) is in agreement with the catalytic potential of Zn(OTf)2 for 2-methylquinolines formation via the Friedländer annulations, the poor yield (45%) of 5 demonstrates the distinctiveness of In(OTf)3 as the most effective catalyst for the tandem Friedlander annulation–Knoevenagel condensation process.

To derive the best operative reaction condition for the In(OTf)3-catalysed synthesis of the 2-SQLs following the Route D (Scheme 1) the two-stage systematic Friedländer annulations–Knoevenagel condensation reaction of 1, 2, and 3 to form 5 was performed under different variation of the various reaction parameters such as the reaction temperature, the amount of In(OTf)3, and the reaction medium (Table 2). The optimum reaction temperature was found to be 100 °C as the increase of the reaction temperature to 120–150 °C (entries 6 and 7, Table 2) did not show any significant increase in the yield which, however, decreased significantly on lowering the reaction temperature to 50–80 °C (entries 2 and 3, Table 2). No product formation was observed in carrying out the reactions at rt (entry 1, Table 2). The optimum catalyst amount was found to be 10 mol%. The use of lesser amount (2.5–7.5 mol%) of In(OTf)3 afforded 5 in decreased yields (entries 8–13, Table 2) and no promising results obtained on prolonging the reaction for further 10 h. No improvement in the product yield was observed using larger amount (15 mol%) of In(OTf)3 (entry 14, Table 2). The use of solvents (hydrocarbon, halogenated hydrocarbon, ethereal, protic polar and aprotic polar) in general showed detrimental effect (entry 15–23, Table 2).

Table 2 Optimisation of the various reaction parameters during the In(OTf)3-catalysed one-pot tandem Friedländer annulation–Knoevenagel condensation involving 1, 2, and 3 to form 5a

image file: c4ra10613j-u2.tif

Entry Xb Solvent Tempc (°C) Time (h) Yieldd (%)
a 1 (0.197 g, 1 mmol) was treated with 2 (0.13 g, 1 mmol, 1 equiv.) in the presence of In(OTf)3 under different operating conditions for 1 h followed by addition of 3 (0.106 g, 1 mmol, 1 equiv.) and continuation of the reaction for further 5 h.b Mol% of the catalyst.c Oil bath temp.d Isolated yield of 5.
1 10 Neat rt (25–30) 5 Traces
2 10 Neat 50 5 20
3 10 Neat 80 5 61
4 10 Neat 100 5 82
5 10 Neat 100 2 80
6 10 Neat 120 5 82
7 10 Neat 150 5 82
8 2.5 Neat 100 5 32
9 2.5 Neat 100 10 41
10 5 Neat 100 5 45
11 5 Neat 100 10 56
12 7.5 Neat 100 5 62
13 7.5 Neat 100 10 71
14 15 Neat 100 5 82
15 10 PhMe 100 5 20
16 10 DCM Reflux 5 35
17 10 1,4-Dioxane Reflux 5 37
18 10 THF Reflux 5 Traces
19 10 EtOH Reflux 5 Traces
20 10 Water Reflux 5 Traces
21 10 MeCN Reflux 5 26
22 10 DMSO 100 5 Traces
23 10 DMF 100 5 15


The optimum time period required for the individual step of tandem process (step 1: Friedländer annulation and step 2: Knoevenagel condensation) was determined by monitoring (GC-MS) the progress of the In(OTf)3-catalysed synthesis of 5 from the reaction of 1, 2, and 3. However, as 5 does not elute under GC-MS condition the progress towards the formation of 4a was determined by GC-MS. Aliquot portions of the reaction mixture during the initial treatment of 1 with 2 at 100 °C under neat condition were withdrawn after 5, 10, and 15 min and was subjected to GC-MS analyses that indicated 43, 73, and 100% conversion to 4a. Thus, the optimal time for the Friedländer annulation step to form the intermediate quinoline was determined as 15 min. Thereafter, separate reactions were carried out to estimate the optimal time for the formation of the 2-styryl quinoline by the reaction of the intermediately formed quinoline 4a with the aldehyde 3. On each occasion, 3 was added after 15 min of the treatment of 1 with 2 at 100 °C under neat condition in the presence of In(OTf)3 (10 mol%) and the reaction was continued for further time period as indicated and the yield was estimated after isolating 5. The optimum time for Knoevenagel condensation was found to be 2 h (81% yield) as the yield of 5 decreased in reducing the reaction time (28, 43, 66, and 72% after 60, 75, 90, and 105 min, respectively) and no enhancement of yield was observed in prolonging the Knoevenagel condensation reaction (81 and 82% after 135 and 150 min, respectively).

Next the applicability of the In(OTf)3-catalysed tandem Friedländer annulation–Knoevenagel condensation was extended for the generalised one-pot synthesis of differently substituted 2-SQLs (Table 3). The reactions proceeded well with substituted aldehydes bearing electron donating group (entries 4, 5, 15, and 16, Table 3), electron withdrawing group (entries 6 and 7, Table 3), halogens (entry 8–10, Table 3), and as well as with different heterocyclic aldehydes such as furan-2-carboxaldehyde (entry 11; Table 3), thiophene-2-carboxaldehyde (entries 12 and 13, Table 3), and pyridine-4-carboxaldehyde (entry 14, Table 3) to afford the desired 2-SQLs in excellent yields. The reactions were also compatible with aldehyde containing acid sensitive dioxalone group (entries 15 and 16, Table 3) and as well as with α,β-unsaturated aromatic aldehyde (entry 17, Table 3). However, with aliphatic aldehydes such as iso-butyraldehyde and cyclohexane carboxaldehyde the 2-SQL formation did not occur and the isolated product was identified as the intermediate 2-methylquinoline 4a. A few representative reactions were carried out using chloro substituted 2-aminobenzophenone and excellent yields were obtained (entry 3, 7, 13, 16 and 17; Table 3). With respect to the variation in the β-ketoester, reactions proceeded well for methyl and ethyl acetoacetates. However no 2-SQL product was formed by using tbutyl acetoacetate and β-diketones such as acetyl acetone and benzoyl acetone. In the case of benzoyl acetone, the corresponding intermediately formed Friedländer product was isolated. In case of acetyl acetone, a complex mixture of products was obtained which could not be purified further.

Table 3 One-pot synthesis of 2-styryl-quinolinesa

image file: c4ra10613j-u3.tif

Entry Product Timeb (h) Yieldc (%)
a 2-Aminobenzophenone (2.5 mmol) was treated with β-ketoester (2.5 mmol, 1 equiv.) in the presence of In(OTf)3 (10 mol%) at 100 °C (oil bath) for 15 min followed by addition of the aldehyde (2.5 mmol, 1 equiv.) and continued stirring for the stipulated time.b The refer time indicate the time after addition of the aldehyde.c Isolated yield of the product.
image file: c4ra10613j-u4.tif
1 R1 = H; R2 = Me; R3 = H 2 80
2 R1 = H; R2 = Et; R3 = H 2 82
3 R1 = Cl; R2 = Et; R3 = H 2 82
4 R1 = H; R2 = Et; R3 = 4-Me 2 81
5 R1 = H; R2 = Et; R3 = 4-OMe 4 75
6 R1 = H; R2 = Me; R3 = 2-NO2 2 83
7 R1 = Cl; R2 = Me; R3 = 4-CF3 2 79
8 R1 = H; R2 = Et; R3 = 4-F 2 82
9 R1 = H; R2 = Et; R3 = 4-Cl   84
10 R1 = H; R2 = Et; R3 = 4-Br 2 81
image file: c4ra10613j-u5.tif
11 R1 = H; R2 = Et; X = O 4 72
12 R1 = H; R2 = Me; X = S 3 73
13 R1 = Cl; R2 = Et; X = S 3 70
image file: c4ra10613j-u6.tif
14 image file: c4ra10613j-u7.tif 4 70
15 R1 = H; R2 = Et 3 81
16 R1 = Cl; R2 = Me 3 81
17 image file: c4ra10613j-u8.tif 4 76


To account for the failure of formation of the desired 2-SQLs in case of tbutyl acetoacetate, acetyl acetone, and benzoyl acetone the corresponding 2-methylquinolines (4c–e) were prepared by treatment with 1 following the Friedländer annulations. The preformed 2-methylquinolines (4a–e) were subjected to Knoevenagel condensation with 3 to form the 2-SQLs. The desired 2-SQLs were obtained in excellent yields from 4a and 4b but no significant amount of the corresponding 2-SQLs were formed from 4c–e (Table 4). In case of 4c and 4e the starting material remained intact and was recovered but a complex product mixture was formed from 4d.

Table 4 The In(OTf)3-catalysed Knoevenagel condensation of preformed 4a–e with 3 to form the corresponding 2-SQLsa

image file: c4ra10613j-u9.tif

Entry 2-Methyl quinoline (4) Product (5) Yieldb (%)
a 2-Methyl quinoline 4 (1 mmol) was treated with 3 (1 mmol, 1 equiv.) in the presence of In(OTf)3 (10 mol%) at 100 °C (oil bath) for 2 h under neat condition.b Isolated yield of the product 5.c Starting materials remained intact and was recovered.d Complex product mixture was obtained which could not be purified further.
1 4a: R = OMe 5a: R = OMe 82
2 4b: R = OEt 5b: R = OEt 81
3 4c: R = OBut 5c: R = OBut Nilc
4 4d: R = Me 5d: R = Me Nild
5 4e: R = Ph 5e: R = Ph Nilc


Thus the lack of formation of the 2-SQLs in case of tbutyl acetoacetate and benzoyl acetone is due to the steric hindrance exhibited by the OBut and the phenyl groups of 4c and 4e during the Knoevenagel condensation with 3. The complex product mixture obtained in case of acetyl acetone might be due to the competitive reaction of 3 with the 2-Me and COMe groups in 4d.

Recycling and reuse of catalyst is an important issue in the context of green chemistry. After completion of the reaction, the reaction mixture was diluted with ethanol and the resulting supernatant liquid was filtered out. The residue was treated with ethanol twice and in each case the supernatant liquid was filtered out. The combined ethanolic extracts were evaporated to dryness and the residue was re-crystallized form ethanol–water (9[thin space (1/6-em)]:[thin space (1/6-em)]1) to obtain the desired product. The solid residue that remained in the reaction flask was collected, washed with ethanol to remove the traces of organic residues and dried to recover In(OTf)3. Fresh batches of reactions involving 1, 2 and 3 were performed using the recovered In(OTf)3 to afforded 5 in good to excellent yields (Table 5).

Table 5 Investigation into the reuse of In(OTf)3a
Entry Run Yieldb (%)
a 1 was treated with 2 (1 equiv.) in the presence of In(OTf)3 (10 mol%) at 100 °C (oil bath) for 15 min followed by addition of 3 (1 equiv.) and the stirring was continued for the further 3 h.b Isolated yield of 5.
1 1st 81
2 2nd 80
3 3rd 76
4 4th 70


Conclusions

The present work describes the first time investigation of metal Lewis acid catalysis for the one-pot domino syntheses of 2-styryl quinolines involving tandem Friedländer annulation and Knoevenagel condensation and found In(OTf)3 to be the stand-alone catalyst for the formation of 2-SQLs. The catalyst can be recovered and reused to afford the desired product in very good to excellent yields. The new catalytic procedure offers the following distinct advantages: (i) one pot tandem synthesis of 2-styryl quinolines with broad substrate scope, (ii) no requirement of additional reagent, and (iii) solvent free condition that fulfill the triple bottom line philosophy of green chemistry.19

Experimental section

General remarks

The glassware used was thoroughly washed and dried in an oven and the experiments were carried out with required precautions. Chemicals and all solvents were commercially available and used without further purification. The NMR spectra were recorded on a 400 MHz NMR spectrometer in CDCl3 or (CD3)2SO or (CD3)2CO using TMS as an internal standard. Chemical shift values (δ) are given in ppm and J values are given in Hz. Splitting pattern are designated as s, singlet; bs, broad singlet; d, doublet; dd, doublet of doublet; t, triplet; m, multiplet. Mass spectra were recorded on using APCI mode and ion trap analyzer. The high resolution mass spectral (HRMS) data were obtained under ESI ionization mode and TOF analyzer. The infra-red (IR) spectra were recorded on a FT-IR spectrometer in the range 4000–600 cm−1 either as neat samples or using KBr for preparing pellets for solid samples. Compounds were routinely checked for their purity on the silica gel GF-254 and visualized under UV at wavelength 254 nm. Melting points were measured with melting point apparatus and were uncorrected. Solvents were removed under rotary vacuum evaporation.

Representative procedure for the one-pot synthesis of 2-styryl-quinolines

Synthesis of (E)-ethyl 4-phenyl-2-styrylquinoline-3-carboxylate 5 (entry 2, Table 4). To the magnetically stirred mixture of 2-aminobenzophenone 1 (0.49 g, 2.5 mmol) and ethyl acetoacetate 2 (0.33 g, 2.5 mmol, 1 equiv.) was added In(OTf)3 (0.14 g, 0.25 mmol, 10 mol%), and the reaction mixture was heated at 100 °C under neat condition. After the complete consumption of 1 (TLC, 15 min), benzaldehyde 3 (0.26 g, 2.5 mmol, 1 equiv.) was added and the stirring was continued further for 2 h. The mixture was diluted with ethanol (15 mL) and the resulting supernatant liquid was filtered out. The residue in the flask was washed with ethanol (2 × 5 mL) and in each case the supernatant liquid was filtered out. The combined ethanolic extracts were evaporated to dryness under rotary vacuum evaporation and the residue was recrystallised from ethanol–water (9[thin space (1/6-em)]:[thin space (1/6-em)]1) to obtain analytically pure product (E)-ethyl 4-phenyl-2-styrylquinoline-3-carboxylate 5 (0.77 g, 82%) as white solid; mp: 149–152 °C; IR (KBr) νmax: 3415, 2921, 1724, 1276, 1070, 766 cm−1; 1H NMR (400 MHz, (CD3)2CO): δ (ppm) 8.18 (d, J = 15.5 Hz, 1H), 8.14 (d, J = 0.7 Hz, 1H), 7.81–7.85 (m, 1H), 7.70 (d, J = 7.16 Hz, 2H), 7.53–7.60 (m, 5H), 7.35–7.46 (m, 6H), 4.14 (q, J = 7.2 Hz, 2H), 0.97 (m, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.0, 156.1, 144.1, 135.3, 130.9, 129.1, 129.0, 128.7, 128.4, 128.3, 128.2, 127.9, 127.7, 127.5, 127.0, 126.5, 126.4, 125.1, 60.4, 14.2; MS (APCI) m/z: 380.21 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H21NO2Na 402.1465; found 402.1463.

The remaining reactions were carried out following this general procedure. The purification was carried out by crystallization in aq. EtOH except the entries 11 and 17 where column chromatography (hexane–EtOAc: 10[thin space (1/6-em)]:[thin space (1/6-em)]1) were used to isolated the desired product. In each occasion, the compounds were characterized (mp, IR, NMR, MS, and HRMS). All of the compounds synthesized under this study [except the (E)-ethyl 2-(4-chlorostyryl)-4-phenylquinoline-3-carboxylate 8: entry 9, Table 3] are new.

(E)-Methyl 4-phenyl-2-styrylquinoline-3-carboxylate (entry 1, Table 3). Yellow solid (0.73 g, 80%); mp: 157–158 °C; IR (KBr) νmax 3573, 3005, 1728, 1566, 1394, 1260, 1040, 764 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.20 (d, J = 8.3 Hz, 1H), 8.12 (d, J = 15.6 Hz, 1H), 7.75–7.80 (m, 1H), 7.66 (d, J = 7.2 Hz, 2H), 7.61 (dd, J = 0.8 Hz & 8.4 Hz, 1H), 7.51–7.56 (m, 3H), 7.41–7.48 (m, 5H), 7.32–7.37 (m, 2H), 3.63 (s, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.3, 155.9, 147.5, 146.2, 144.0, 135.9, 131.1, 129.9, 129.8, 129.5, 129.4, 129.2, 128.3, 128.10, 127.5, 126.4, 126.3, 125.0, 61.3; MS (APCI) m/z: 366.18 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C25H19NO2Na 388.1308; found 388.1302.
(E)-Ethyl 6-chloro-4-phenyl-2-styrylquinoline-3-carboxylate (entry 3, Table 3). Yellow solid (0.84 g, 82%); mp: 143–145 °C; IR (KBr) νmax 3573, 2988, 1728, 1566, 1447, 1260, 1069, 750 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.10 (dd, J = 4.1 Hz & 13.4 Hz, 2H), 7.61–7.68 (m, 3H), 7.50–7.53 (m, 4H), 7.31–7.41 (m, 6H), 4.10 (q, J = 7.0 Hz, 2H), 0.96 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.0, 151.3, 146.5, 145.9, 136.9, 136.5, 135.1, 132.6, 131.4, 131.2, 129.4, 128.9, 128.8, 128.7, 128.5, 127.7, 127.6, 126.5, 125.2, 124.0, 61.7, 13.7; MS (APCI) m/z: 414.21 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H20ClNO2Na 436.1075; found 436.1075.
(E)-Ethyl 2-(4-methylstyryl)-4-phenylquinoline-3-carboxylate (entry 4, Table 3). White solid (0.79 g, 81%); mp: 141–142 °C; IR (KBr) νmax: 3413, 2925, 1726, 1275, 1069, 764 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.13 (d, J = 8.8 Hz, 1H), 8.02 (d, J = 14.7 Hz, 1H), 7.84 (d, J = 6.7 Hz, 1H), 7.48–7.60 (m, 7H), 7.38 (t, J = 2.5 Hz, 2H), 7.22–7.26 (m, 3H), 4.11 (q, J = 7.0 Hz, 2H), 2.34 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 166.8, 152.1, 148.1, 146.6, 136.5, 136.2, 135.8, 130.3, 129.4, 129.3, 128.7, 128.6, 128.4, 128.2, 127.6, 127.0, 126.6, 126.4, 125.6, 124.4, 61.8, 21.0, 13.6; MS (APCI) m/z 394.23 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C27H23NO2Na 416.1621; found 416.1618.
(E)-Ethyl 2-(4-methoxystyryl)-4-phenylquinoline-3-carboxylate (entry 5, Table 3). White solid (0.77 g, 75%); mp: 156–158 °C; IR (KBr) νmax: 2954, 1718, 1510, 1254, 1062, 762 cm−1; 1H NMR (400 MHz, (CD3)2SO): δ (ppm) 8.09 (s, 1H), 7.99 (d, J = 16.0 Hz, 1H), 7.83 (s, 1H), 7.63 (d, J = 8.3 Hz, 2H), 7.51 (t, J = 16.2 Hz, 5H), 7.35 (d, J = 3.7 Hz, 2H), 7.12 (d, J = 15.5 Hz, 1H), 7.00 (d, J = 8.3 Hz, 2H), 4.09 (d, J = 7.0 Hz, 2H), 3.79 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, (CD3)2SO): δ (ppm) 167.9, 160.6, 150.8, 147.8, 146.5, 136.1, 135.3, 131.5, 129.6, 129.5, 129.2, 128.9, 128.8, 127.6, 127.0, 126.5, 125.2, 121.7, 114.9, 61.8, 55.7, 13.9; MS (APCI) m/z: 410.19 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C27H23NO3Na [M + Na]+, 432.1570; found 432.1572.
(E)-Methyl 2-(2-nitrostyryl)-4-phenylquinoline-3-carboxylate (entry 6, Table 3). White solid (0.88 g, 83%); mp: 185–188 °C; IR (KBr) νmax: 2926, 1721, 1516, 1275, 1066, 764 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.48 (d, J = 15.2 Hz, 1H), 8.18 (d, J = 8.4 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.74–7.81 (m, 2H), 7.59–7.65 (m, 2H), 7.44–7.52 (m, 6H), 7.37–7.39 (m, 2H), 7.31 (d, J = 15.7 Hz, 1H), 3.56 (s, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.8, 150.0, 148.5, 148.1, 147.2, 135.7, 133.1, 132.5, 131.5, 130.7, 129.9, 129.5, 129.2, 128.9, 128.3, 127.2, 126.7, 126.5, 125.9, 124.7, 52.3; MS (APCI) m/z: 425.20 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H20N2O4Na 447.1315; found 447.1312.
(E)-Methyl 6-chloro-4-phenyl-2-[4-(trifluoromethyl)styryl]quinoline-3-carboxylate (entry 7, Table 3). White solid (0.95 g, 79%); mp: 133–134 °C; IR (KBr) νmax: 3005, 1728, 1566, 1478, 1276, 1126, 1067, 750 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.09–8.12 (m, 2H), 7.63–7.70 (m, 5H), 7.52–7.56 (m, 4H), 7.33–7.37 (m, 3H), 3.60 (s, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.5, 150.6, 146.5, 146.4, 139.8, 135.2, 134.9, 133.0, 131.7, 131.2, 130.6, 130.3, 129.1, 128.9, 127.7, 127.6, 126.6, 126.3, 125.74, 125.70, 125.4, 125.3, 122.7, 52.5; MS (APCI) m/z: 468.10 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H17ClF3NO2Na 490.0792; found 490.0792.
(E)-Ethyl 2-(4-fluorostyryl)-4-phenylquinoline-3-carboxylate (entry 8, Table 3). White solid (0.81 g, 82%); mp: 147–148 °C; IR (KBr) νmax: 2959, 1723, 1508, 1232, 1066, 764 cm−1; 1H NMR (400 MHz, (CD3)2CO): δ (ppm) 8.13–8.17 (m, 2H), 7.75–7.86 (m, 3H), 7.52–7.59 (m, 5H), 7.34–7.44 (m, 3H), 7.21 (t, J = 8.3 Hz, 2H), 4.13 (q, J = 7.1 Hz, 2H), 0.96 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, (CD3)2CO): δ (ppm) 168.4, 151.3–148.9 (d, 1JFC = 245 Hz), 147.4, 136.6, 135.6, 133.91–133.88 (d, 4JFC = 3 Hz), 131.6, 130.4–130.3 (d, 3JFC = 8Hz), 129.5, 129.2, 128.1, 127.9, 127.2, 126.5, 124.9, 116.7–116.5 (d, 2JFC = 22 Hz), 62.1, 14.0; MS (APCI) m/z: 398.24 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd C26H20FNO2Na 420.1370; found 420.1368.
(E)-Ethyl 2-(4-chlorostyryl)-4-phenylquinoline-3-carboxylate8 (entry 9, Table 3). White solid (0.87 g, 84%); mp: 150–152 °C; IR (KBr) νmax: 2926, 1723, 1489, 1216, 1066, 764 cm−1; 1H NMR (400 MHz, (CD3)2SO): δ (ppm) 8.15 (d, J = 8.3 Hz, 1H), 8.04 (d, J = 15.6 Hz, 1H), 7.86 (d, J = 7.2 Hz, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.58 (t, J = 3.2 Hz, 4H), 7.50 (d, J = 8.3 Hz, 3H), 7.39 (t, J = 3.2 Hz, 2H), 7.31 (d, J = 15.6 Hz, 1H), 4.10 (q, J = 7.0 Hz, 2H), 0.88 (t, J = 7.0 Hz, 3H); MS (APCI) m/z: 414.12 (M + H)+.
(E)-Ethyl 2-(4-bromostyryl)-4-phenylquinoline-3-carboxylate (entry 10, Table 3). White Solid (0.92 g, 81%); mp: 163–165 °C; IR (KBr) νmax: 2926, 1723, 1487, 1233, 1072, 764 cm−1; 1H NMR (400 MHz, (CD3)2SO): δ (ppm) 8.15 (d, J = 8.4 Hz, 1H), 8.01 (d, J = 15.6 Hz, 1H), 7.87 (t, J = 7.5 Hz, 1H), 7.69–7.57 (m, 8H), 7.51 (d, J = 8.2 Hz, 1H), 7.38 (d, J = 3.9 Hz, 2H), 7.33 (d, J = 15.6 Hz, 1H), 4.10 (q, J = 6.9 Hz, 2H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.3, 156.4, 147.4, 146.1, 145.1, 136.0, 130.1, 129.9, 129.5, 129.4, 129.2, 128.3, 128.1, 128.1, 127.9, 127.6, 126.3, 126.0, 125.0, 61.2, 13.6; MS (APCI) m/z: 458.20 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H20BrNO2Na 480.0570; found 480.0572.
(E)-Ethyl 2-[2-(furan-2-yl)vinyl]-4-phenylquinoline-3-carboxylate (entry 11, Table 3). White solid (0.66 g, 72%); mp: 165–166 °C; IR (KBr) νmax: 3447, 2930, 1725, 1545, 1172, 819 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.13 (d, J = 8.4 Hz, 1H), 7.93 (d, J = 15.3 Hz, 1H), 7.71–7.75 (m, 1H), 7.56 (d, J = 8.4 1H), 7.47–7.53 (m, 4H), 7.39–7.43 (m, 3H), 7.26 (d, J = 15.3 Hz, 1H), 6.58 (d, J = 3.3 Hz, 1H), 6.47–6.48 (m, 1H), 4.13 (q, J = 7.1 Hz, 2H), 0.98 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.2, 152.9, 150.8, 148.1, 146.6, 143.3, 135.8, 130.4, 129.5, 129.4, 128.4, 128.2, 127.0, 126.5, 126.4, 125.7, 123.4, 122.4, 112.1, 112.0, 61.5, 13.6; MS (APCI) m/z: 370.18 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C24H19NO3Na 392.1257; found 392.1258.
(E)-Methyl 4-phenyl-2-[2-(thiophen-2-yl)vinyl]quinoline-3-carboxylate (entry 12, Table 3). White solid (0.67 g, 73%); mp: 160–162 °C; IR (KBr) νmax: 3456, 2918, 1723, 1543, 1275, 764 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.08–8.15 (m, 2H), 7.73 (t, J = 8.1 Hz, 1H), 7.57 (m, 1H), 7.49–7.52 (m, 4H), 7.32–7.45 (m, 5H), 7.14 (d, J = 15.5 Hz, 1H), 3.59 (s, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.9, 151.1, 148.1, 146.8, 139.5, 135.8, 130.5, 130.4, 130.3, 129.5, 129.3, 129.2, 128.5, 128.3, 126.7, 126.6, 126.5, 125.6, 125.5, 125.3, 124.1, 52.3; MS (APCI) m/z: 372.15 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C23H17NO2SNa 394.0872; found 394.0869.
(E)-Ethyl 6-chloro-4-phenyl-2-[2-(thiophen-2-yl)vinyl]quinoline-3-carboxylate (entry 13, Table 3). Yellow solid (0.73 g, 70%); mp: 174–176 °C; IR (KBr) νmax: 2925, 1724, 1576, 1470, 1275, 1123, 1014, 751, cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.22 (d, J = 15.2 Hz, 1H), 8.05 (d, J = 9.0 Hz, 1H), 7.65 (dd, J = 2.3 Hz & 8.9 Hz, 1H), 7.50–7.53 (m, 4H), 7.35–7.38 (m, 2H), 7.26–7.30 (m, 2H), 7.10 (d, J = 15.2 Hz, 1H), 7.04–7.06 (m, 1H), 4.11 (q, J = 7.1 Hz, 2H), 1.00 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 167.8, 151.0, 146.5, 145.9, 142.0, 135.1, 132.5, 131.4, 131.0, 129.6, 129.4, 128.9, 128.8, 128.5, 127.9, 127.5, 126.43, 126.39, 125.2, 123.2, 61.7, 13.7; MS (APCI) m/z: 420.08 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C24H18ClNO2SNa 442.0639; found 442.0636.
(E)-Ethyl 4-phenyl-2-[2-(pyridin-3-yl)vinyl]quinoline-3-carboxylate (entry 14, Table 3). White solid (0.66 g, 70%); mp: 154–159 °C; IR (KBr) νmax: 2981, 1723, 1543, 1217, 806 cm−1; 1H NMR (400 MHz, (CD3)2CO): δ (ppm) 8.11 (dd, J = 0.7 Hz & 1.6 Hz, 1H), 7.99 (d, J = 15.3 Hz, 1H), 7.80–7.84 (m, 1H), 7.67 (t, J = 0.9 Hz, 1H), 7.25–7.58 (m, 6H), 7.40–7.43 (m, 2H), 7.24 (d, J = 15.3 Hz, 1H), 6.78 (dd, J = 0.3 Hz & 3.2 Hz, 1H), 6.59 (dd, J = 1.8 Hz & 3.4 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 0.96 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 171.1, 154.2, 150.3, 149.7, 148.9, 148.9, 138.1, 135.1, 134.9, 130.2, 129.8, 129.5, 128.7, 128.6, 126.8, 126.0, 125.8, 123.7, 118.8, 60.4, 14.2; MS (APCI) m/z 381.21 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C25H20N2O2Na 403.1417; found 403.1417.
(E)-Ethyl 2-{2-(benzo[d][1,3]dioxol-5-yl)vinyl}-4-phenylquinoline-3-carboxylate (entry 15, Table 3). White solid (0.85 g, 81%); mp: 142–144 °C; IR (KBr) νmax: 2925, 1721, 1488, 1253, 1234, 1038, 803 cm−1; 1H NMR (400 MHz, (CD3)2SO): δ (ppm) 8.10 (d, J = 8.2 Hz, 1H), 7.96 (d, J = 15.5 Hz, 1H), 7.83 (t, J = 6.9 Hz, 1H), 7.46–7.55 (m, 5H), 7.34–7.36 (m, 3H), 7.19 (d, J = 7.6 Hz, 1H), 7.11 (d, J = 15.4 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 6.07 (s, 2H), 4.09 (q, J = 6.7 Hz, 2H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, (CD3)2SO): δ (ppm) 167.8, 150.8, 148.7, 148.5, 147.8, 146.6, 136.3, 135.4, 131.5, 130.7, 129.6, 129.5, 129.2, 128.9, 127.6, 127.1, 126.5, 125.3, 123.8, 122.4, 109.1, 106.7, 101.9, 61.8, 13.9; MS (APCI) m/z 424.23 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C27H21NO4Na 446.1363; found 446.1361.
(E)-Methyl 2-{2-(benzo[d][1,3]dioxol-5-yl)vinyl}-6-chloro-4-phenylquinoline-3-carboxylate (entry 16, Table 3). Yellow solid (0.89 g, 81%); mp: 175–176 °C; IR (KBr) νmax: 3788, 3573, 3006, 1729, 1562, 1446, 1255, 1040, 750 cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.07 (d, J = 9.0 Hz, 1H), 8.00 (d, J = 15.4 Hz, 1H), 7.65 (dd, J = 2.3 Hz & J = 9.0 Hz, 1H), 7.50–7.52 (m, 4H), 7.35–7.37 (m, 2H), 7.07–7.14 (m, 3H), 6.83 (d, J = 7.9 Hz, 1H), 6.00 (s, 2H), 3.60 (s, 1H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.6, 151.4, 148.5, 148.2, 146.6, 146.0, 136.7, 135.1, 132.4, 131.5, 131.05, 130.93, 129.2, 128.8, 128.5, 126.2, 125.2, 123.5, 122.0, 108.5, 106.3, 101.4, 52.4; MS (APCI) m/z 444.21 (M + H)+; HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C26H18ClNO4Na 466.0817; found 466.0820.
Ethyl 6-chloro-4-phenyl-2-[(1E,3E)-4-phenylbuta-1,3-dien-1-yl]quinoline-3-carboxylate (entry 17, Table 3). Yellow solid (0.83 g, 76%); mp: 130–132 °C; IR (KBr) νmax: 1733, 1564, 1260, 1219, 1067, 750, cm−1; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.06 (d, J = 9.0 Hz, 1H), 7.92 (dd, J = 10.8 Hz & 14.7 Hz, 1H), 7.65 (dd, J = 2.3 Hz & 9.0 Hz, 1H), 7.48–7.54 (m, 6H), 7.34–7.37 (m, 4H), 7.28 (d, J = 7.3 Hz, 1H), 7.06 (q, J = 10.9 Hz & 15.7 Hz, 1H), 6.85–6.95 (m, 2H), 4.09 (q, J = 7.1 Hz, 2H), 0.94 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ (ppm) 168.0, 151.4, 146.6, 145.8, 137.3, 137.0, 135.1, 132.4, 131.4, 131.1, 129.4, 128.8, 128.7, 128.5, 128.4, 128.3, 127.7, 127.6, 126.9, 126.3, 125.2, 61.7, 13.6; MS (APCI) m/z 554.21 (M + H)+; HRMS (ESI) m/z calcd for C28H22ClNO2Na+ [M + Na+], 462.1231; found 462.1232.

Representative procedure for large scale synthesis of 2-styryl quinolines and recovery/reuse of In(OTf)3 during the one-pot synthesis of 2-styryl-quinolines. Synthesis of (E)-ethyl 4-phenyl-2-styrylquinoline-3-carboxylate 5: to the magnetically stirred mixture of 1 (4.92 g, 25 mmol) and 2 (3.25 g, 25 mmol, 1 equiv.) was added In(OTf)3 (1.40 g, 10 mol%) and the reaction mixture was heated at 100 °C under neat. After the complete consumption of 1 (TLC, 30 min), 3 (2.65 g, 25 mmol, 1 equiv.) was added and the stirring was continued further for 3 h. The mixture was diluted with ethanol (100 mL) and the resulting supernatant liquid was filtered out. The solid residue that remained in the flask was washed with ethanol (2 × 10 mL). The combined ethanolic extracts were evaporated to dryness under rotary vacuum evaporation and the crude product was recrystallised from ethanol–water (9[thin space (1/6-em)]:[thin space (1/6-em)]1) to obtain analytically pure product 5 (7.77 g, 82%) as white solid. The solid residue (catalyst) that remained in the flask was collected and dried to obtain the recovered In(OTf)3 (1.26 g, 90%). The reaction was repeated with 1, 2 and 3 at 5 mmol, 2.5 mmol, and 1 mmol scales in the presence of the recovered In(OTf)3 (280 mg, 140 mg, and 57 mg, respectively) to afforded 5 in 80, 76, and 70% yields, respectively.

Acknowledgements

DK thanks CSIR, New Delhi for the award of Research Associateship.

Notes and references

  1. J. P. Michael, Nat. Prod. Rep., 2002, 19, 742 RSC.
  2. (a) S. Kumar, S. Bawa and H. Gupta, Mini-Rev. Med. Chem., 2009, 9, 1648 CrossRef CAS; (b) D. Ding and F. Jian-Xin, Chin. J. Org. Chem., 2007, 27, 1318 Search PubMed.
  3. (a) K. Mekouar, J. F. Mouscadet, D. Desmaële, F. Subra, H. Leh, D. Savouré, C. Auclair and J. d'Angelo, J. Med. Chem., 1998, 41, 2846 CrossRef CAS PubMed; (b) F. Zouhiri, J. F. Mouscadet, K. Mekouar, D. Desmaële, D. Savouré, H. Leh, F. Subra, M. L. Bret, C. Auclair and J. d'Angelo, J. Med. Chem., 2000, 43, 1533 CrossRef CAS PubMed; (c) F. Zouhiri, D. Desmaële, J. d'Angelo, M. Ourevitch, J. F. Mouscadet, H. Leh and M. Le Bret, Tetrahedron Lett., 2001, 42, 8189 CrossRef CAS; (d) J. Polanski, F. Zouhiri, L. Jeanson, D. Desmaële, J. d'Angelo, J. F. Mouscadet, R. Gieleciak, J. Gasteiger and M. Le Bret, J. Med. Chem., 2002, 45, 4647 CrossRef CAS PubMed; (e) M. Normand-Bayle, C. Benard, F. Zouhiri, J. F. Mouscadet, H. Leh, C. M. Thomas, G. Mbemba, D. Desmaële and J. d'Angelo, Bioorg. Med. Chem. Lett., 2005, 15, 4019 CrossRef CAS PubMed.
  4. V. Sridharan, C. Avendano and J. C. Menendez, Tetrahedron, 2009, 65, 2087 CrossRef CAS PubMed.
  5. R. Cinar, J. Nordmann, E. Dirksen and T. J. Müller, Org. Biomol. Chem., 2013, 11, 2597 CAS.
  6. J. Barluenga, M. Tomás, J. A. Ló pez-Pelegrín and E. Rubio, Tetrahedron Lett., 1997, 38, 3981 CrossRef CAS.
  7. V. Sridharan, C. Avendaño and J. C. Menéndez, Tetrahedron, 2007, 63, 673 CrossRef CAS PubMed.
  8. The only report used the ionic liquid [Hmim]TFA in 50 mol% to promote the reaction, M. Dabiri, P. Salehi, M. Baghbanzadeh and M. S. Nikcheh, Tetrahedron Lett., 2008, 49, 5366 CrossRef CAS PubMed.
  9. J. Potosky, Drug Discovery Today, 2005, 10, 115 CrossRef.
  10. S. D. Roughley and A. M. Jordan, J. Med. Chem., 2011, 54, 3451 CrossRef CAS PubMed.
  11. M. Poliakoff and P. Licence, Nature, 2007, 450, 810 CrossRef CAS PubMed.
  12. (a) J. O. Metzger, Angew. Chem., Int. Ed., 1998, 37, 2975 CrossRef CAS; (b) K. Tanaka and F. Toda, Chem. Rev., 2000, 100, 1025 CrossRef CAS PubMed.
  13. D. J. C. Constable, C. Jimenez-Gonzalez and R. K. Henderson, Org. Process Res. Dev., 2007, 11, 133 CrossRef CAS.
  14. A. Sarkar, S. Raha Roy, D. Kumar, C. Madaan, S. Rudrawar and A. K. Chakraborti, Org. Biomol. Chem., 2012, 10, 281 CAS.
  15. The C-2 proton of the MeIm cation plays significant role in attributing catalytic potential to imidazolium-based ILs in promoting various organic reactions (a) A. Sarkar, S. Raha Roy, N. Parikh and A. K. Chakraborti, J. Org. Chem., 2011, 76, 7132 CrossRef CAS PubMed; (b) S. Raha Roy, P. S. Jadhavar, K. Seth, K. K. Sharma and A. K. Chakraborti, Synthesis, 2011, 2261 Search PubMed; (c) A. Sarkar, S. Raha Roy and A. K. Chakraborti, Chem. Commun., 2011, 47, 4538 RSC; (d) S. Raha Roy and A. K. Chakraborti, Org. Lett., 2010, 12, 3866 CrossRef PubMed; (e) A. K. Chakraborti and S. Raha Roy, J. Am. Chem. Soc., 2009, 131, 6902 CrossRef CAS PubMed; (f) A. K. Chakraborti, S. Raha Roy, D. Kumar and P. Chopra, Green Chem., 2008, 10, 1111 RSC.
  16. (a) D. N. Kommi, D. Kumar, K. Seth and A. K. Chakraborti, Org. Lett., 2013, 15, 1158 CrossRef CAS PubMed; (b) D. N. Kommi, D. Kumar and A. K. Chakraborti, Green Chem., 2013, 15, 756 RSC; (c) D. N. Kommi, P. S. Jadhavar, D. Kumar and A. K. Chakraborti, Green Chem., 2013, 15, 798 RSC; (d) D. Kumar, K. Seth, D. N. Kommi, S. Bhagat and A. K. Chakraborti, RSC Adv., 2013, 3, 15157 RSC; (e) D. N. Kommi, D. Kumar, R. Bansal, R. Chebolu and A. K. Chakraborti, Green Chem., 2012, 14, 3329 RSC; (f) R. Chebolu, D. N. Kommi, D. Kumar, N. Bollineni and A. K. Chakraborti, J. Org. Chem., 2012, 77, 10158 CrossRef CAS PubMed; (g) S. V. Chankeshwara and A. K. Chakraborti, Org. Lett., 2006, 8, 3259 CrossRef CAS PubMed; (h) G. L. Khatik, R. Kumar and A. K. Chakraborti, Org. Lett., 2006, 8, 2433 CrossRef CAS PubMed; (i) A. K. Chakraborti, S. Rudrawar, K. B. Jadhav, G. Kaur and S. V. Chankeshwara, Green Chem., 2007, 9, 1335 RSC.
  17. (a) K. Seth, S. Raha Roy, D. N. Kommi, B. V. Pipaliya and A. K. Chakraborti, J. Mol. Catal. A: Chem., 2014, 392, 164 CrossRef CAS PubMed; (b) K. Seth, S. Raha Roy, B. V. Pipaliya and A. K. Chakraborti, Chem. Commun., 2013, 49, 5886 RSC; (c) N. Parikh, D. Kumar, S. Raha Roy and A. K. Chakraborti, Chem. Commun., 2011, 47, 1797 RSC.
  18. K. C. Lekhok, D. Bhuyan, D. Prajapati and R. C. Boruah, Mol. Diversity, 2010, 14, 841 CrossRef CAS PubMed.
  19. P. Tundo, P. Anastas, D. S. Black, J. Breen, T. Collins, S. Memoli, J. Miyamoto, M. Polyakoff and W. Tumas, Pure Appl. Chem., 2000, 72, 1207 CAS.

Footnote

Electronic supplementary information (ESI) available: Spectral data of all compounds, scanned spectra (1H of all compounds and 13C of unknown compounds). See DOI: 10.1039/c4ra10613j

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.